Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

Background: The disease burden of acute myeloid leukemia (AML) continues to pose a significant public health challenge globally. Mitochondria play a critical role in tumor development and progression ...

Introduction: We present Quantum Adaptive Search (QAGS), a hybrid quantum-classical algorithm for global optimization of multivariate functions. The method employs an adaptive mechanism that ...

Google’s June 2025 Core Update just finished. What’s notable is that while some say it was a big update, it didn’t feel disruptive, indicating that the changes may have been more subtle than game ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

Recursion Pharmaceuticals' stock has plummeted 57% since February, with significant failures in its lead drug REC-994 and other clinical candidates, raising concerns about its AI-driven drug discovery ...

MicroAlgo Inc. announced its research on the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to address complex combinatorial optimization problems using quantum computing.

Abstract: Fault detection has long been a hot research issue for industry. Many common algorithms such as principal component analysis, recursive transformed component statistical analysis and moments ...

The SEO industry is undergoing a profound transformation in 2025. As large language models (LLMs) increasingly power search experiences, success now depends on withstanding traditional algorithm ...